West Pharmaceutical Services Inc (WST) stock
Close on Nov 12, 2026Market cap $28.65BP/E 46.2Yield 0.21%
West Pharmaceutical Services Inc grew revenue 12.6% to $3.40B over the twelve months to Sep 30, 2026. Operating income rose 32.7% to $780.20M, moving the operating margin from 19.5% to 23.0%. Free cash flow was $453.40M, up 19.6% from a year earlier. At the latest close the market valued the company at $28.65B, 46.2 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $28.65B
- P/E ratio
- 46.2
- Price to sales
- 8.44
- Price to book
- 9.65
- Dividend yield
- 0.21%
- Free cash flow yield
- 1.58%
Fundamentals
- Revenue
- $3.40B
- Net income
- $638.90M
- EPS, diluted
- $8.91
- Free cash flow
- $453.40M
- Book value per share
- $41.92
- Diluted shares
- 71M
Trading
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Previous close
- $412.86
- Open
- $411.39
- Day's range
- $406.69 – $415.90
- Volume
- 378,122
- Average volume (20 days)
- 766,070
- Index membership
- S&P 500 (since Jun 2020), Russell 1000, Russell 3000
- Beta (5 years)
- 1.05
- 52-week range
- $223.83 – $438.27
- RSI (14 days)
- 64.4
- Volatility (1 year)
- 31.4%
- Relative volume
- 0.51×
- WACC
- 10.1%
On 1 of our idea list: Dividend growers
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | WST | S&P 500 | Difference | WST per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +11.9% | -2.7% | +14.6 pts | ||
| 3 months | +16.8% | -1.7% | +18.5 pts | ||
| Year to date | +49.8% | +11.9% | +37.9 pts | ||
| 1 year | +50.5% | +12.0% | +38.6 pts | ||
| 3 years | +21.3% | +78.2% | −56.8 pts | +6.7% | +21.2% |
| 5 years | -0.6% | +73.2% | −73.9 pts | -0.1% | +11.6% |
| 10 years | +449.1% | +309.6% | +139.4 pts | +18.6% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases West Pharmaceutical Services filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Update
About West Pharmaceutical Services
Surgical & Medical Instruments & Apparatus
West Pharmaceutical Services, Inc. designs and manufactures containment and delivery systems for injectable drugs and healthcare products. The company operates through two segments: Proprietary Products and Contract-Manufactured Products. Its Proprietary Products segment provides primary packaging components such as stoppers, seals, syringes, and cartridges, alongside drug delivery devices, reconstitution systems, and analytical lab services. The Contract-Manufactured Products segment provides custom design, molding, and automated assembly of complex devices used in surgical, ophthalmic, diagnostic, and drug delivery applications. West serves leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide.
Company profile, executives and historyWest Pharmaceutical Services stock: common questions
What is West Pharmaceutical Services's stock price?
WST closed at $411.30 on Nov 12, 2026, down 0.38% on the day. Over the past 52 weeks it traded between $223.83 and $438.27.
What is West Pharmaceutical Services's market cap?
West Pharmaceutical Services was worth $28.65B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is WST's P/E ratio?
WST trades at 46.2 times earnings, based on diluted earnings per share of $8.91 over the twelve months to Sep 30, 2026.
How much revenue does West Pharmaceutical Services make?
West Pharmaceutical Services reported revenue of $3.40B for the twelve months to Sep 30, 2026, up 12.6% from a year earlier.
Does West Pharmaceutical Services pay a dividend?
Yes. West Pharmaceutical Services paid $0.86 per share over the last twelve months, a yield of 0.21% at the latest price, and has raised its annual dividend 17 years in a row.
When does West Pharmaceutical Services report earnings next?
West Pharmaceutical Services is expected to report Q4 FY2026 results on Feb 11, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has WST stock performed over the past year?
Including dividends, WST returned +50.5% over the past year, against +12.0% for the S&P 500.
How many WST shares are sold short?
2M shares were sold short at the latest FINRA report, 2.61% of the float, or 2.3 days of average trading volume.
Who are West Pharmaceutical Services's competitors?
Companies most similar to West Pharmaceutical Services by business, industry and size include STVN, TFX, MMSI, GMED, PODD.
See a number that looks wrong?